Clinical trial
Effects of GH and Pioglitazone in Viscerally Obese Adults With IGT
NCT00352287 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of GH and Pioglitazone in Viscerally Obese Adults With IGT
- Lead sponsor
- Stanford University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2003
- Completion date
- April 30, 2005
- Enrollment
- 60
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
impaired glucose tolerance, metabolic syndrome, obesity